My position and my quality responsibility
Release time:
2023-03-21
As a drug inspector, quality is self-evident to me. Combined with their own positions, I talk about the following points.
Stand on your post and perform your duties diligently.
Consolidate the ideological foundation in strengthening learning, thinking and practicing. If a person wants to make a difference, he must have firm ideals and beliefs, and he must have a higher spiritual realm, and these all come from learning and from the transformation of the world outlook. Since I have been engaged in the drug testing industry, I have always strictly adhered to the bottom line of quality and safety as the working principle. Persevere in enriching yourself and arming yourself with theoretical knowledge. As far as possible, the theoretical learning results into specific practical activities, into improving the ability to do a good job of inspection.
Promote the implementation of tasks in due diligence. In line with the attitude of being responsible for the quality of the unit and drugs, I ensure that the test results are true and reliable, and do my job well. Adhere to the center does not shift, the key and difficult points do not waver, take the initiative to undertake, take the initiative to strengthen the ability to operate independently. At the same time, we should always keep in mind the principles of work and enhance our sense of mission.
in strict self-discipline in the exercise of solid style. I deeply realize that a person's growth and progress is the result of company training, leadership care, and colleague help. As a drug testing personnel, we are also required to be strict with ourselves, strictly require ourselves in our work, pay attention to the rigor of testing work everywhere, and put an end to carelessness. Consciously accept supervision, can strictly abide by the rules and regulations of the laboratory.
face up to the short board and make up for the deficiency.
Since I was engaged in drug testing, I have exercised all aspects of my abilities and improved my overall quality, but there are also some problems and deficiencies. In the face of difficult problems in the work, we still have an evasive mentality; in the work, we only stay at the level of relying on past experience, lack of awareness of studying new situations and solving new problems in combination with our work, and it is not enough to make efforts in deep research and mastery.
Strive forward and continue with a new chapter.
quality and safety problems should not be underestimated. In view of the above deficiencies, I will correct them from the following points: on the one hand, we should strengthen learning and constantly improve the level of thinking; on the other hand, in the face of difficult problems, we should make careful plans and overcome them in stages. Do words first, improve work initiative, think of work in front, do in front, strive for work initiative, and develop a "strict, accurate, quick and practical" work style. Strict word support, adhere to strict standards, with the spirit of wanting to compare with the sky, work hard in deep drilling and detailed research, and strive to ensure that quality problems do not go wrong. Constantly enhance the sense of professionalism and responsibility, concentrate your mind and energy on your work, do a good job in testing, and keep your post.
"
Accumulation of strength, there is no victory. All the wisdom of the work, there is no success", on the road to ensure the quality of drugs, to untie the small knots of thought, to make up their own ability of the short board, to rush for quick success and instant benefits in a timely manner to pour cold water, to fear the former dare to raise the whip, to fully ensure the quality and safety of a force. (Zhong Yaping)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page